150 Results (Page 1 of 6)
Mexico Markets Research Reports
Mexico Healthcare Claims Management Market Analysis
This report presents a strategic analysis of the Mexico Healthcare Claims Management Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Mexico Healthcare Claims Management Market, offering unmatched value, accuracy, and expert insights.
Mexico Digital Health Market Analysis
The Mexico Digital Health market is projected to grow from $3.17 Bn in 2022 to $xx Bn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market will be driven by the adoption of digital health solutions, legislative efforts, and an increase in investments. The market is segmented by solution, by deployment & by end-use. Some of the major players include Philips, GE HealthCare & Sofia.
Mexico Pain Management Devices Market Analysis
This report presents a strategic analysis of the Mexico Pain Management Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Mexico Pain Management Devices Market, offering unmatched value, accuracy and expert insights.
Mexico Genomics Market Analysis
The Mexico Genomics market was valued at $489.8 Mn in 2023 and is predicted to grow at a CAGR of 16.75% from 2023 to 2030, to $1,448 Mn by 2030. The key drivers of the market include the need for advancements in cancer treatments, increasing trend of personalized medicines, and increasing genomics projects. The prominent players of the Mexico genomics market are National Institute of Genomic Medicine (INMEGEN), the National Laboratory of Genomics for Biodiversity of Mexico (LANGEBIO), Genomica Medica, BGI Mexico, and National Autonomous University of Mexico (UNAM), among others.
Mexico Kidney Cancer Therapeutics Market Analysis
Mexico Kidney Cancer Therapeutics Market was valued at $94.3 Mn in 2023 and is predicted to grow at a CAGR of 5.11% from 2023 to 2030, to $133.7 Mn by 2030. The key drivers of this industry include Increasing Incidence of Kidney Cancer, Advances in targeted therapies, Growing geriatric population, awareness, and early detection. The industry is primarily dominated by Pfizer Inc., AstraZeneca, Bristol-Myers Squibb Company, Dr Reddy's Laboratories Ltd, Endo International plc), Teva Pharmaceutical Industries Ltd, and Sun Pharmaceutical Industries Ltd among others.
Mexico Neurology Drugs Market Analysis
This report presents a strategic analysis of the Mexico Neurology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Mexico Neurology Drugs Market, offering unmatched value, accuracy and expert insights.
Mexico COVID-19 Clinical Trials Market Analysis
This report presents a strategic analysis of the Mexico COVID-19 Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Mexico COVID-19 Clinical Trials Market, offering unmatched value, accuracy and expert insights.
Mexico Medical Digital Imaging System Market Analysis
The Mexico Medical Digital Imaging System Market was valued at $457.5 Mn in 2023 and is predicted to grow at a CAGR of 8.45% from 2023 to 2030, to $807.23 Mn by 2030. The key drivers of this industry include an aging population, technological advancements, and rising chronic diseases. The industry is primarily dominated by players such as Siemens Healthineers, GE Healthcare, Philips Healthcare, and Canon Medical Systems among others.
Mexico Dental Caries Detectors Market Analysis
The Mexico Dental Caries Detectors Market was valued at $3.4 Mn in 2023 and is predicted to grow at a CAGR of 9.15% from 2023 to 2030, to $6.3 Mn by 2030. Mexico Dental Caries Detectors Market is growing due to the Prevalence of dental caries, Rising awareness, and Advanced imaging and diagnostics. The market is primarily dominated by players such as Sirona Dental Systems, Dentsply Sirona, KaVo Kerr, Ivoclar Vivadent, Planmeca Oy, Adec Technologies, 3M ESPE, Morita Corporation, Woodpecker Medical Instruments Co., Softdent.
Mexico Pharmacy Automation Device Market Analysis
The Mexico Pharmacy Automation Device Market was valued at $82.5 Mn in 2023 and is predicted to grow at a CAGR of 10.15% from 2023 to 2030, to $162.3 Mn by 2030. Mexico Pharmacy Automation Device Market is growing due to Increasing Demand for Efficiency, Rising Demand for Pharmaceuticals, Increasing adoption among end-users. The market is primarily dominated by players such as Amerisource Bergen Corporation, Accu-Chart Plus Healthcare Systems, Omnicell, Inc., McKesson Corporation; Pearson Medical Technologies, Baxter.
Mexico Cardiac Pacemakers Market Analysis
The Mexico Cardiac Pacemakers Market was valued at $60.70 Mn in 2023 and is predicted to grow at a CAGR of 3.45% from 2023 to 2030, to $76.97 Mn by 2030. The key drivers of this industry include the aging population, rising chronic disease, and medical tourism. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
Mexico Clinical Nutrition for Cancer Care Market Analysis
The Mexico Clinical Nutrition for Cancer Care Market was valued at $84.5 Mn in 2023 and is predicted to grow at a CAGR of 5.29% from 2023 to 2030, to $121.2 Mn by 2030. The key drivers of the market include the increasing prevalence of cancer, improved healthcare infrastructure, and rising disposable incomes. The prominent players of the Mexico Clinical Nutrition for Cancer Care Market are Nestlé Health Science, Abbott Nutrition, B. Braun Melsungen AG, and Fresenius Kabi, among others.
Mexico Clinical Nutrition for Diabetes Care Market Analysis
The Mexico Clinical Nutrition for Diabetes Care Market was valued at $32.25 Mn in 2023 and is predicted to grow at a CAGR of 5.03% from 2023 to 2030, to $45.47 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Nestle Health Science, Sanofi, Pfizer Inc., and Abbott Nutrition among others.
Mexico Gram-Negative Infection Therapeutics Market Analysis
The Mexico Gram-Negative Infection Therapeutics Market was valued at $223.1 Mn in 2023 and is predicted to grow at a CAGR of 6.15% from 2023 to 2030 to $338.8 Mn by 2030. This growth is driven by increasing prevalence, growing awareness, and rising investment in R&D. Major players in this market include Baxter and GlaxoSmithKline plc (GSK), among others.
Mexico Home Infusion Therapy Market
The Mexico Home Infusion Therapy Market was valued at $539.4 Mn in 2023 and is predicted to grow at a CAGR of 8.35% from 2023 to 2030, to $945.6 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the Mexico Home Infusion Therapy Market are Option Care Health, Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
Mexico Hepatitis A Therapeutics Market Analysis
The Mexico Hepatitis A Therapeutics Market was valued at $11.06 Mn in 2023 and is predicted to grow at a CAGR of 2.45% from 2023 to 2030 to $13.1 Mn by 2030. Factors including growing prevalence, an aging population, and personal hygiene and sanitation challenges propel the market. Leading companies in this sector include F. Hoffmann-La Roche Ltd. and Merck & Co. Inc., among others.
Mexico Acne Therapeutics Market Analysis
This report presents a strategic analysis of the Mexico Acne Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Mexico Acne Therapeutics Market, offering unmatched value, accuracy and expert insights.
Mexico Lymphoma Therapeutics Market Analysis
Mexico's Lymphoma Therapeutics Market was valued at $41.64 Mn in 2023 and is predicted to grow at a CAGR of 8.30 % from 2023 to 2030, to $72.76 Mn by 2030. The key drivers of this industry include high lymphoma incidence, healthcare expenditure, and the geriatric population. The industry is primarily dominated by Abbott Laboratories, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, and Johnson & Johnson Services, Inc. among others.
Mexico Head and Neck Cancer Therapeutics Market Analysis
The Mexico Head and Neck Cancer Therapeutics Market was valued at $7.32 Mn in 2023 and is predicted to grow at a CAGR of 12.50% from 2023 to 2030, to $16.69 Mn by 2030. The key drivers of this industry include advancement in research, government initiatives, and awareness programs. The industry is primarily dominated by players such as Pfizer, Bristol Myers Squibb, Merck & Co., Novartis, and AstraZeneca among others.
Mexico Liver Disease Drugs Market Analysis
This report presents a strategic analysis of the Mexico Liver Disease Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Mexico Liver Disease Drugs Market, offering unmatched value, accuracy and expert insights.
Mexico Skin Antiseptic Products Market Analysis
This report presents a strategic analysis of the Mexico Skin Antiseptic Products Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Mexico Skin Antiseptic Products Market, offering unmatched value, accuracy and expert insights.
Mexico Cardiovascular Diseases Therapeutics Market Analysis
The Mexico cardiovascular disease therapeutics market is expected to witness growth from $2.44 Bn in 2022 to $4.34 Bn in 2030 with a CAGR of 7.47% for the year 2022-2030. The improvement in health infrastructure and spending and the development of new therapeutics in Mexico are responsible for the expansion of the market. The Mexico cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by the end user. Liomont, Vitalmex, and Sanofi are the major players in the Mexico cardiovascular disease therapeutics market.
Mexico Over The Counter (OTC) Analgesics Market Analysis
This report presents a strategic analysis of the Mexico Over The Counter (OTC) Analgesics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Mexico Over The Counter (OTC) Analgesics Market, offering unmatched value, accuracy and expert insights.
Mexico Chronic Cough Therapeutics Market Analysis
Mexico Chronic Cough Therapeutics Market was valued at $95 Mn in 2022 and is estimated to reach $179 Mn in 2030, exhibiting a CAGR of 8.35% during the forecast period. The main driver behind the growth of the chronic cough therapeutics market is the extensive prevalence of chronic respiratory infections, often signaled by the occurrence of chronic cough. Presently, key participants in this market consist of Cipla Inc., Reckitt Benckiser Group plc., Hikma Pharmaceuticals Plc, Merck, Novartis, Bellus Health, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Bristol-Myers Squibb, and Bayer.
Mexico Connected Healthcare Market Analysis
Mexico connected healthcare market is projected to grow from $995.4 Mn in 2022 to $7469.23 Mn by 2030, registering a CAGR of 28.65% during the forecast period of 2022-30. The main factors driving the growth would be increasing technological adoption, the ageing population, the rising prevalence of chronic diseases and government support. The market is segmented by type, function and by application. Some of the major players include Okani, Prosperia, Cuentame, Medtronic, Honeywell, Siemens Healthineer and GE Healthcare.